SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001933414-24-000009
Filing Date
2024-04-09
Accepted
2024-04-09 07:15:39
Documents
8
Period of Report
2024-04-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A mlys-proxystatementx202404.htm DEF 14A 405730
2 card1a.jpg GRAPHIC 198624
3 card2a.jpg GRAPHIC 311016
4 card3a.jpg GRAPHIC 130515
5 card4a.jpg GRAPHIC 921813
6 image_2a.jpg GRAPHIC 33474
7 logoa.jpg GRAPHIC 23441
8 picture2a.jpg GRAPHIC 28462
  Complete submission text file 0001933414-24-000009.txt   2672571
Mailing Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087
Business Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087 (888) 378-6240
Mineralys Therapeutics, Inc. (Filer) CIK: 0001933414 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41614 | Film No.: 24831106
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)